Cell transplantation in heart failure: where do we stand in 2016?
作者信息
MacArthur John W, Goldstone Andrew B, Cohen Jeffrey E, Hiesinger William, Woo Y Joseph
机构信息
Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA, USA.
Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA, USA
出版信息
Eur J Cardiothorac Surg. 2016 Sep;50(3):396-9. doi: 10.1093/ejcts/ezw230.
Abstract
摘要
相似文献
1
Cell transplantation in heart failure: where do we stand in 2016?心力衰竭中的细胞移植：2016年我们处于什么阶段？
Eur J Cardiothorac Surg. 2016 Sep;50(3):396-9. doi: 10.1093/ejcts/ezw230.
2
Stem cell therapy for chronic heart failure.慢性心力衰竭的干细胞治疗
Curr Opin Cardiol. 2015 May;30(3):301-10. doi: 10.1097/HCO.0000000000000167.
3
Stem cell therapy: promising treatment in heart failure?干细胞疗法：心力衰竭的有前景的治疗方法？
Curr Heart Fail Rep. 2013 Mar;10(1):73-80. doi: 10.1007/s11897-012-0128-2.
4
Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial.用于缺血性心力衰竭的自体骨髓来源干细胞：REGENERATE-IHD试验。
Regen Med. 2009 Jan;4(1):119-27. doi: 10.2217/17460751.4.1.119.
5
Somatic stem cell transplantation for the failing heart.用于衰竭心脏的体干细胞移植。
Scand J Surg. 2007;96(2):131-9. doi: 10.1177/145749690709600208.
6
Stem cell delivery to the heart: clarifying methodology and mechanism.干细胞向心脏的递送：阐明方法和机制。
Crit Care Med. 2007 Nov;35(11):2654-6. doi: 10.1097/01.CCM.0000288086.96662.40.
7
Heart failure and regenerative cardiology.心力衰竭与再生心脏病学
Regen Med. 2006 Mar;1(2):153-9. doi: 10.2217/17460751.1.2.153.
8
[Stem cell transfer in myocardial infarction].[心肌梗死中的干细胞移植]
Dtsch Med Wochenschr. 2006 Apr 21;131(16):881-3. doi: 10.1055/s-2006-939862.
9
The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: update 2016.欧洲心脏病学会特别工作组关于自体成体干细胞用于治疗急性心肌梗死和心力衰竭的临床研究的共识：2016年更新版
Eur Heart J. 2017 Oct 14;38(39):2930-2935. doi: 10.1093/eurheartj/ehw640.
10
Current status of cell-based therapy for heart failure.心力衰竭细胞治疗的现状
Curr Heart Fail Rep. 2013 Jun;10(2):165-76. doi: 10.1007/s11897-013-0134-z.
引用本文的文献
1
Potential use of superparamagnetic iron oxide nanoparticles for in vitro and in vivo bioimaging of human myoblasts.超顺磁性氧化铁纳米粒子在人肌母细胞体外和体内生物成像中的潜在应用。
Sci Rep. 2018 Feb 27;8(1):3682. doi: 10.1038/s41598-018-22018-0.
2
Angiogenesis precedes cardiomyocyte migration in regenerating mammalian hearts.血管生成先于心细胞迁移出现在再生的哺乳动物心脏中。
J Thorac Cardiovasc Surg. 2018 Mar;155(3):1118-1127.e1. doi: 10.1016/j.jtcvs.2017.08.127. Epub 2017 Nov 29.
本文引用的文献
1
Xenotransplantation of Bone Marrow-Derived Human Mesenchymal Stem Cell Sheets Attenuates Left Ventricular Remodeling in a Porcine Ischemic Cardiomyopathy Model.骨髓来源的人间充质干细胞片的异种移植减轻猪缺血性心肌病模型中的左心室重构。
Tissue Eng Part A. 2015 Aug;21(15-16):2272-80. doi: 10.1089/ten.TEA.2014.0036. Epub 2015 Jul 14.
2
Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts.人类胚胎干细胞衍生的心肌细胞可使非人类灵长类动物的心脏再生。
Nature. 2014 Jun 12;510(7504):273-7. doi: 10.1038/nature13233. Epub 2014 Apr 30.
3
Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices.间充质前体细胞作为当代左心室辅助装置接受者的辅助治疗手段
Circulation. 2014 Jun 3;129(22):2287-96. doi: 10.1161/CIRCULATIONAHA.113.007412. Epub 2014 Mar 28.
4
Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial.自体间充质干细胞应用于接受冠状动脉搭桥术的患者时，可在局部功能、组织灌注和纤维化负担方面产生一致的改善：心脏手术患者间充质干细胞治疗的前瞻性随机研究（PROMETHEUS）试验。
Circ Res. 2014 Apr 11;114(8):1302-10. doi: 10.1161/CIRCRESAHA.114.303180. Epub 2014 Feb 24.
5
Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.经心内膜心肌间质干细胞和单核骨髓细胞治疗缺血性心肌病：TAC-HFT 随机试验。
JAMA. 2014 Jan 1;311(1):62-73. doi: 10.1001/jama.2013.282909.
6
Enhanced survival of transplanted human induced pluripotent stem cell-derived cardiomyocytes by the combination of cell sheets with the pedicled omental flap technique in a porcine heart.细胞片与带蒂大网膜瓣技术联合应用增强移植人心诱导多能干细胞源性心肌细胞的存活率：在猪心脏中的研究。
Circulation. 2013 Sep 10;128(11 Suppl 1):S87-94. doi: 10.1161/CIRCULATIONAHA.112.000366.
7
Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function.急性心肌梗死后早期或晚期冠状动脉内注射骨髓来源的单核细胞对左心室整体功能的影响。
Circulation. 2013 May 14;127(19):1968-79. doi: 10.1161/CIRCULATIONAHA.112.001035. Epub 2013 Apr 17.
8
Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.心力衰竭中心肌发生干细胞治疗：C-CURE（心力衰竭中心肌发生干细胞治疗）多中心随机试验与谱系特异性生物制剂。
J Am Coll Cardiol. 2013 Jun 11;61(23):2329-38. doi: 10.1016/j.jacc.2013.02.071. Epub 2013 Apr 10.
9
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.骨髓单个核细胞应用时间和方式对急性心肌梗死后左心室功能的影响：TIME 随机试验。
JAMA. 2012 Dec 12;308(22):2380-9. doi: 10.1001/jama.2012.28726.
10
Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.经心内膜注射异体与自体骨髓间充质干细胞治疗缺血性心肌病的比较：POSEIDON 随机试验。
JAMA. 2012 Dec 12;308(22):2369-79. doi: 10.1001/jama.2012.25321.
Zotero 插件